William S. Baldwin

The oncostatic action of melatonin in an ovarian carcinoma cell line

Abstract: Melatonin is reported to reduce proliferation in many cell types, but the effect is small and the results are inconsistent. Information on the mechanism by which melatonin exerts its antiproliferative effects might provide insight into the variability of the response. In an ovarian adenocarcinoma cell line (BG‐1), we find that melatonin at concentrations of 10−9‐10−7 M caused a 20–25% reduction in cell number. Melatonin also resulted in a similar reduction in [3H]‐thymidine incorporation with no significant increase in cell death as measured by trypan blue incorporation. The Kd for melatonin reduction in cell number was ∼ 5 × 10−10 M. Melatonin ML2 receptors have a Kd for melatonin binding in the low nM range and are linked to the production of the calcium mobilizing agent inositol‐1, 4, 5‐trisphosphate (IP3). To investigate whether melatonin signaling involves an increase in cytosolic‐free calcium, BG‐1 cells were loaded with the calcium sensitive indicator, fura‐2. Acute addition of melatonin (10−5‐10−9 M) did not alter cytosolic calcium. Addition of the putative nuclear receptor agonist CGP52608 caused a dose‐dependent inhibition of cell number with a Kd of ∼ 2 × 10−9 M. Addition of CGP52608 caused a similar reduction in [3H]‐thymidine incorporation. Neither melatonin (10−8 M‐10−5 M) nor CGP52608 at concentrations below 10−7 M induced cell death associated with the inhibition of cell proliferation; however, addition of CGP52608 at a high dose (10−7 M) caused an increase in cell death, consistent with apoptosis. Growth inhibition by melatonin or CGP52608 did not alter the percentage of cells in G1 versus S/G2/M.

In vivo biotransformation of testosterone by phase I and II detoxication enzymes and their modulation by 20-hydroxyecdysone in Daphnia magna

Abstract Phase I and phase II chemical detoxication processes were elucidated in Daphnia magna using in vivo techniques and [ 14 C]testosterone as a substrate. Testosterone was used because this compound undergoes multiple biotransformations and its metabolites are well characterized in other species. In addition, regulation of these processes by the endogenous steroid hormone, 20-hydroxyecdysone, was investigated. Daphnids produced at least ten polar phase I metabolites and four nonpolar phase I metabolites of testosterone. Six of the ten polar metabolites have been identified as monohydroxy-products of testosterone. The polar metabolites were preferentially excreted while the nonpolar metabolites were preferentially retained by the daphnids. In addition, testosterone and all phase I metabolites were also excreted as glucose conjugates. A polar metabolite designated ‘C’ was preferentially conjugated with glucose over the other metabolites. Testosterone and its polar phase I metabolites were also excreted as sulfate conjugates with 2α-hydroxytestosterone being the predominant sulfate-conjugated metabolite. In contrast to glucose conjugation, no nonpolar phase I metabolites of testosterone were sulfate conjugated. Twenty-four hour pre-exposure of daphnids to 4.2 μM 20-hydroxyecdysone did not affect phase I metabolism of testosterone, but differentially modulated phase II conjugation in a manner suggesting the presence of at least two glucosyltransferases and two sulfotransferases. Treatment with 20-hydroxyecdysone significantly increased the elimination of sulfate conjugates due largely to increased sulfate conjugation of unmetabolized testosterone. These results demonstrate that daphnids can convert polycyclic compounds to multiple polar and nonpolar metabolites resulting from both phase I and phase II biotransformations, and that some phase II activities are under the regulatory control of 20-hydroxyecdysone.

The anti-carcinogenic plant compound indole-3-carbinol differentially modulates P450-mediated steroid hydroxylase activities in mice

Indole-3-carbinol (I3C), a component of cruciferous vegetables, exhibits anti-carcinogenic activity in a variety of model systems. This activity has been attributed in part to the induction of cytochrome P450 CYP1A subfamily members and the resulting increased metabolic inactivation of chemical carcinogens. The present study was undertaken to assess the effects of I3C on several constitutive P450 activities that contribute to both carcinogen and steroid hormone metabolism. Mice were administered I3C in their diet at estimated daily doses of 250, 500 and 750 mg/kg for 1 week. Liver microsomes from treated and untreated mice were subsequently assayed for CYP1A-mediated ethoxy-resorufin O-deethylase (EROD) activity, estradiol 2-hydroxylase activity and seven different testosterone hydroxylase activities. I3C elevated EROD, estradiol 2-hydroxylase and testosterone 6 alpha-hydroxylase activities in a dose-dependent manner. The other six testosterone hydroxylase activities were not significantly affected by in vivo treatment with I3C. In addition to its effects on steroid hydroxylase activities, I3C also elevated NADPH-cytochrome P450 reductase activity, a necessary component to the P450 monooxygenase system. We next examined the direct in vitro effects of I3C and its acid condensation products, as are generated in the stomach following ingestion, on the P450 catalytic activities. Testosterone 6 beta-hydroxylase, the major testosterone hydroxylase activity in untreated mice, was significantly inhibited (IC50 approximately 12 micrograms/ml) by the acid condensation products of I3C. In contrast, all other P450 activities were not appreciably affected by I3C or its acid condensation products. These results indicate that I3C can elicit both inductive and suppressive effects on the constitutive P450s that participate in carcinogen and steroid hormone metabolism. This pleiotropic effect on hepatic catalytic enzymes may contribute to the anti-carcinogenic properties of this compound.

Melatonin: receptor-mediated events that may affect breast and other steroid hormone-dependent cancers.

Epidemiological studies have suggested a possible link between extremely low frequency electromagnetic fields (EMFs) and increased rates of certain cancers. One cancer that has been postulated to be associated with EMF exposure is breast cancer, for which increased rates have been reported among electricians. These cancer associations are weak, and the link to EMF exposures remains tenuous. Understanding the mechanisms by which EMFs could have biological effects will help in elucidating the risk, if any, from EMFs. One hypothesis that has received considerable attention involves reduction of melatonin levels by EMFs. This hypothesis suggests that loss of melatonin affects a variety of hormonal processes such as estrogen homeostasis and thereby may increase breast cancer rates. Since this theory was first presented, putative melatonin receptors have been cloned, providing new tools with which to examine melatonins mechanism of action and the melatonin hypothesis. These receptors are found in nuclear and membrane fractions of cells. The nuclear receptors (retinoid Z receptors) are found both in the brain and in non‐neural tissues, whereas the membrane‐bound receptors are found primarily in neural tissue and have a higher affinity for melatonin. These receptors may control a variety of hormonal and immunological functions, including the release of gonadotropins from the hypothalamus and pituitary and 5‐lipoxygenase activity in B lymphocytes. This Working Hypothesis briefly reviews our current knowledge of melatonin receptors and then provides theories on how the inactivation of melatonin receptors may cause cancer and suggests areas of research for addressing this question. Mol. Carcinog. 21:149–155, 1998.

BG-1 OVARIAN CELL LINE: AN ALTERNATIVE MODEL FOR EXAMINING ESTROGEN- DEPENDENT GROWTH IN VITRO

SummaryExamination of estrogen-responsive processes in cell culture is used to investigate hormonal influence on cancer cell growth and gene expression. Most experimental studies have used breast cancer cell lines, in particular MCF7 cells, to investigate estrogen responsiveness. In this study we examined an ovarian cancer cell line, BG-1, which is highly estrogen-responsive in vitro. This observation, plus the fact that the cells are of ovarian rather than mammary gland origin, makes it an attractive alternative model. 17β-Estradiol, epidermal growth factor, and insulin-like growth factor induced proliferation of BG-1 and MCF7 cells. Viability was dependent on these growth factors in BG-1 cells, but not in MCF7 cells. Therefore, we examined the differences between these two cell lines with respect to estrogen and growth factor receptors. BG-1 cells have twice as many estrogen receptors as MCF7 cells, and BG-1 cells have higher insulin-like growth factor-1 and epidermal growth factor receptor levels than MCF7 cells. This may also explain why BG-1 cells proliferate 56% more robustly in serum and show more serum dependence in culture. In both BG-1 and MCF7 cells, epidermal growth factor receptor number is low (<20 000/cell), while insulin-like growth factor-1 receptor level was highest in estrogen receptor positive cell lines. For example, insulin-like growth factor-1 receptor was higher in BG-1 and MCF7 cells than in estrogen receptor negative cells (HeLa>MDA-MB-435>HBL100). In conclusion, BG-1 cells are an excellent model for understanding hormone responsiveness in ovarian tissue and an alternative for examining estrogen receptor-mediated and insulin-like growth factor-1/epidermal growth factor/estrogen cross-talk processes because of their sensitivity to these factors.

Using mummichog (Fundulus heteroclitus) arrays to monitor the effectiveness of remediation at a Superfund site in Charleston, South Carolina, USA

We previously developed a cDNA array for mummichogs (Fundulus heteroclitus), an estuarine minnow, that is targeted for identifying differentially expressed genes from exposure to polycyclic aromatic hydrocarbons and several metals, including chromium. A chromium-contaminated Superfund site at Shipyard Creek in Charleston, South Carolina, USA, is undergoing remediation, providing us a unique opportunity to study the utility of arrays for monitoring the effectiveness of site remediation. Mummichogs were captured in Shipyard Creek in Charleston prior to remediation (2000) and after remediation began (2003 and 2005). Simultaneously, mummichogs were collected from a reference site at the Winyah Bay National Estuarine Research Reserve (NERR) in Georgetown, South Carolina, USA. The hepatic gene expression pattern of fish captured at Shipyard Creek in 2000 showed wide differences from the fish captured at NERR in 2000. Interestingly, as remediation progressed the gene expression pattern of mummichogs captured at Shipyard Creek became increasingly similar to those captured at NERR. The arrays acted as multidimensional biomarkers as the number of differentially expressed genes dropped from 22 in 2000 to four in 2003, and the magnitude of differential expression dropped from 3.2-fold in 2000 to no gene demonstrating a difference over 1.5-fold in 2003. Furthermore, the arrays indicated changes in the bioavailability of chromium caused by hydraulic dredging in the summer of 2005. This research is, to our knowledge, the first report using arrays as biomarkers for a weight-of-evidence hazard assessment and demonstrates that arrays can be used as multidimensional biomarkers to monitor site mitigation because the gene expression profile is associated with chromium bioavailability and body burden.

Hexavalent chromium reduces larval growth and alters gene expression in mummichog (Fundulus heteroclitus)

Hexavalent chromium [Cr(VI)] is a common bioavailable metal ion that causes oxidative stress, DNA adducts, and perturbs gene expression. Changes in gene expression are useful biomarkers of toxicant exposure that provide information about an organisms health, adaptability, and toxicant-specific effects. Therefore, we developed a cDNA array for the estuarine sentinel species mummichog (Fundulus heteroclitus). Mummichog larvae were exposed to concentrations ranging from 0 to 24 mg/L (462 microM) of Cr(VI) for 30 d, and growth was measured to determine the no-observable-effect concentration (1.5 mg/L) and the lowest-observable-effect concentration (3 mg/L). Body burdens from Cr(VI)-exposed fish showed a dose-dependent increase and were inversely correlated to body weight. Mummichog larvae exposed to Cr(VI) differentially expressed 16 genes in a dose-dependent manner, including GLUT-2, L-FABP, ATPase synthase 8, type II keratin, TBT-binding protein, and complement component C3-2. Many of these genes are involved in energy metabolism or growth, which is consistent with the reduced growth observed. In subsequent experiments, adults were exposed to Cr(VI) for 7 d at 0, 1.5, or 3 mg/L, because adult mummichog are used in monitoring Superfund sites. Hexavalent chromium altered the expression of 10 genes in adult liver, including HGFA, H-FABP, and complement component C3-2. Many of these genes also are involved in energy metabolism. The mummichog arrays provide a potential mechanism for the effects of Cr(VI) on growth. We anticipate using these arrays and the data they provide to monitor effects at polluted sites, to assess the bioavailability of chromium at these sites, and to investigate the efficacy of remediation in chromium-polluted estuaries.

HIV type 1 Tat inhibits tumor necrosis factor alpha-induced repression of tumor necrosis factor receptor p55 and amplifies tumor necrosis factor alpha activity in stably tat-transfected HeLa Cells.

The human immunodeficiency virus type 1 (HIV-1) Tat protein is a key regulatory protein in the HIV-1 replication cycle. Tat interacts with cellular transcriptional factors and cytokines, such as tumor necrosis factor (TNF-alpha), and alters the expression of a variety of genes in HIV-1-infected and noninfected cells. To further elucidate the mechanisms by which HIV-1 Tat amplifies the activity of TNF-alpha, we transfected the HIV-1 tat gene into an epithelial (HeLa) cell line. We observed that Tat-expressing cells had increased NF-kappa B-dependent trans-activational activity due to enhanced NF-kappa B--DNA binding in response to TNF-alpha treatment. Tumor necrosis factor receptor (TNFR) p55 was the prominent receptor, as neutralizing antibodies to TNFR p55, but not to TNFR p75, blocked TNF-alpha-mediated NF-kappa B activation. Furthermore, tat-transfected cells were more sensitive to TNF-alpha-induced cytotoxicity and only the neutralizing antibodies to TNFR p55 completely protected the cells. To determine whether TNFR p55 was involved in amplification of cellular response to TNF-alpha by HIV-1 Tat, we investigated the effect of TNF-alpha on TNFR p55 expression in the tat-transfected cells. TNF-alpha treatment resulted in a reduction in both TNFR p55 mRNA and protein levels in the control cells but not in the tat-transfected cells as determined with Northern blot and Western blot analyses, respectively. Our results indicate that HIV-1 Tat may inhibit TNF-alpha-induced repression of TNFR p55 and thereby amplify TNF-alpha activity in these stably transfected cells.